PMEF
CVS icon

Point72 Middle East FZE’s CVS Health CVS Stock Holding History

Point72 Middle East FZE’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-96,600
Closed -$7.63M – 340
2023
Q4 		$7.63M Buy
96,600
+78,500
+434% +$5.59M 0.23% 105
2023
Q3 		$1.26M Sell
18,100
-81,500
-82% -$5.77M 0.04% 498
2023
Q2 		$6.89M Sell
99,600
-63,800
-39% -$4.54M 0.19% 134
2023
Q1 		$12.1M Buy
163,400
+143,800
+734% +$12.1M 0.41% 55
2022
Q4 		$1.83M Buy
+19,600
New +$1.89M 0.08% 332

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Point72 Middle East FZE's CVS Position: Q4 2023 in Review

Point72 Middle East FZE sold out of CVS Health (CVS) in Q4 2023, closing a stake of 359,262 shares — an estimated $25.6M sold.

Point72 Middle East FZE first reported a position in CVS in Q4 2022 and held it in 4 quarters. The position peaked at $25.1M in Q3 2023. 2,260 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

  • Point72 Middle East FZE reported no remaining CVS Health position as of Q4 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 359,262 CVS Health shares in Q4 2023, an estimated $25.6M.
  • Point72 Middle East FZE first reported a position in CVS Health in Q4 2022 and held it in 4 quarters.
  • Point72 Middle East FZE's CVS Health position peaked at $25.1M in Q3 2023.
  • 2,260 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.